HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells

EUROPEAN RESPIRATORY JOURNAL(2015)

引用 0|浏览23
暂无评分
摘要
The putative progenitor alveolar epithelial type II (ATII) cells restore epithelial barrier integrity by transdifferentiating into alveolar type I (ATI) cells. We investigated to see whether inhibition of histone deacetylases (HDAC) could reverse epithelial to mesenchymal (EMT) like intermediate phenotype during differentiation of ATII cells. Methods: Primary human ATII cells in monolayer or co-cultured with fibroblasts were treated with 5µM of HDAC inhibitor (HDACi) MS-275 (MS) and 10ng/ml of TGFβ to assess molecular targets. Results: MS upregulated the gradual downregulated expression of surfactant protein C (SPC) - marker of ATII cells - in both monolayer and co-culture (p Conclusion: These results show that HDAC inhibitors may regulate EMT-like phenotype during transdifferentiation of ATII cells and promote expression of SPC by repression of transcription factor Hop.
更多
查看译文
关键词
Interstitial lung disease,Epithelial cell,Lung injury
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要